Archive Newsletter
-
11.20.26 -- Want More Sustainable Biopharma Packaging? Try These Levers
11/20/2026
11/20/26 Cell & Gene Newsletter
-
11.19.26 -- OPCU: Strengthening Large Molecule Programs From Manufacturing To Fill-Finish
11/19/2026
11/19/26 Cell & Gene Newsletter
-
11.19.26 -- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
11/19/2026
11/19/26 Cell & Gene Newsletter
-
11.18.26 -- OPCU: Strengthening Cell And Gene Therapy Programs With Robust Analytics
11/18/2026
11/18/26 Cell & Gene Newsletter
-
11.18.26 -- What Will It Take To Turn CGT Innovation Into Market Success?
11/18/2026
11/18/26 Cell & Gene Newsletter
-
11.17.26 -- What If The Body Could Make Its Own Medicine?
11/17/2026
11/17/26 Cell & Gene Newsletter
-
11.17.26 -- Reducing Tech Transfer Risk In Autologous CAR T Automation
11/17/2026
11/17/26 Cell & Gene Newsletter
-
11.17.26 -- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
11/17/2026
11/17/26 Cell & Gene Newsletter
-
11.16.26 -- Rethinking The Inputs Behind Scalable T-Cell Therapy
11/16/2026
11/16/26 Cell & Gene Newsletter
-
11.16.26 -- Rethinking Commercial Viability In CGT With Treehill Partners' Ali Pashazadeh
11/16/2026
11/16/26 Cell & Gene Newsletter